Anika Therapeutics, Inc.

About

Anika Therapeutics, Inc. is a leading global joint preservation company headquartered in Bedford, Massachusetts, specializing in regenerative orthopedic solutions for early intervention care. The company develops and manufactures innovative medical devices and therapies designed to help patients restore active living through advanced joint preservation technologies. As a specialized healthcare manufacturer, Anika focuses on proprietary hyaluronic acid-driven solutions that address orthopedic conditions across multiple body areas including shoulder, knee, foot, ankle, hand, and wrist applications. Their comprehensive product portfolio encompasses regenerative solutions such as the Integrity Implant System, which utilizes their proprietary Hyaff hyaluronic acid technology in porous, knitted scaffolds for tissue regeneration. The company manufactures targeted therapies for osteoarthritis pain management, including Cingal, Monovisc, and the Orthovisc series, positioning themselves at the forefront of joint preservation innovation. Anika Therapeutics leverages advanced biomaterial manufacturing processes and regenerative medicine technologies to develop products that support tissue repair and restoration. With a commitment to enhancing patient outcomes and supporting medical professionals, Anika combines rigorous manufacturing standards with cutting-edge research and development capabilities. Their strategic focus on profitable, science-based solutions has established them as a trusted partner in the orthopedic medical device industry, serving healthcare providers worldwide with clinically proven joint preservation therapies that help patients maintain mobility and quality of life.